Terumo Corporation

Equities

Market Closed - Japan Exchange Other stock markets 12:00:00 17/02/2026 pm IST			5-day change	1st Jan Change
1,946.50 ^JPY	+1.96%		-6.42%	-14.25%

13/02	Terumo Corporation, Q3 2026 Earnings Call, Feb 13, 2026
13/02	Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025	CI

Published on 05/14/2025 - Modified on 05/14/2025 at 01:30 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you very much for taking the time to attend Terumo's Financial Results Presentation for the Fourth Quarter of 2025.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

13/02	Terumo Corporation, Q3 2026 Earnings Call, Feb 13, 2026
13/02	Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
10/02	New purchases in the Asia-Pacific Investor portfolio
13/01	Terumo Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 05:15 PM
06/01	Terumo launches Surtract(TM) safety syringe in the United States	RE
13/11	US Shutdown End, FX, Earnings Nudge Asian Markets Higher	MT
12/11	Terumo Corporation, Q2 2026 Earnings Call, Nov 12, 2025
12/11	Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI
12/11	Terumo Corporation Announces Dividend for the Second Quarter End of 2026, Payable on December 2, 2025; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2026	CI
12/11	Terumo Attributable Profit Jumps 22% in Fiscal H1; Cuts Full Year Profit Forecasts	MT
12/11	Terumo Corporation Reports Earnings Results for the Half Year Ended September 30, 2025	CI
11/11	Orchestra BioMed Q3 revenue beats expectations	RE
30/25/30	Terumo Corporation completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.	CI
28/25/28	Orchestra BioMed and Terumo enter into new $30 million Virtue SAB strategic agreements	RE
24/25/24	Terumo Interventional Systems Announces its New OPUSWAVE Dual Sensor Imaging System and DualView®? Imaging Catheter Receive FDA 510(k) Clearance	CI